Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
4D Molecular Therapeutics Inc. | Chief Business Officer | Stock Option (Right to Buy) | 35K | Feb 1, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
FDMT | 4D Molecular Therapeutics Inc. | Feb 1, 2022 | 1 | $0 | 4 | Feb 3, 2022 | Chief Business Officer |
FDMT | 4D Molecular Therapeutics Inc. | Jun 7, 2021 | 1 | $0 | 4 | Jun 9, 2021 | Chief Business Officer |
FDMT | 4D Molecular Therapeutics Inc. | Jun 7, 2021 | 0 | $0 | 3 | Jun 9, 2021 | Chief Business Officer |